News & Articles
Selected Filters:
The Atellica IM TnIH test helps predict patient risk of cardiac events/death
This high-sensitivity troponin test from Siemens Healthineers is the only one in the US with a prognostic risk intended use
Discussing diagnostic trends and innovations after ADLM 2024
Discover how sustainability, efficiency, automation and other trends are impacting diagnostic innovation and improving healthcare outcomes
New survey reveals burnout in clinical labs impacts patient care and staff safety
Optimism that automation and AI will help tackle challenges
Close the distance between providers and care with human-centered engineering in the lab
At the ADLM 2024 Clinical Lab Expo (July 28–August 1, Chicago, Booth #501), Siemens Healthineers will demonstrate what is achievable for laboratory testing with human-centered engineering and automation.
Siemens Healthineers offers new way to detect heart failure
NT‑proBNPII Assay now part of Atellica cardiac testing menu
High-sensitivity troponin at the point of care
Professor of Emergency Medicine at the University of Manchester highlights the promise of point-of-care high-sensitivity troponin assays in the emergency department
Neurofilament light chain blood test for multiple sclerosis achieves CE mark
New blood test developed by Siemens Healthineers in collaboration with Novartis aims to improve the management of MS
New reproductive assay from Siemens Healthineers
The Anti-Müllerian Hormone Assay reveals a patient's ovarian reserve information
Siemens Healthineers launches Atellica CI Analyzer
The new compact testing system is designed to tackle a range of challenges faced by today's laboratories
Siemens Healthineers launches next-gen hematology analyzers
Removes workflow barriers to improve patient care
Siemens Healthineers announces FDA Emergency Use Authorization for rapid COVID-19 antigen self-test
Rapid antigen testing provides results in just 15 minutes and the information can help reduce the risk of COVID-19 exposure
Siemens Healthineers SARS-CoV-2 testing portfolio detects Omicron variant
The lab-based Atellica and ADVIA Centaur SARS-CoV-2 Antigen Assays (CoV2Ag) are well designed to detect Omicron variant
Siemens Healthineers now launching Sysmex CN-3000 and CN-6000 Hemostasis Systems
The fully automated CN-3000 and CN-6000 Systems bring mid- and high-volume coagulation testing to laboratories
Siemens Healthineers AI-based COVID-19 severity algorithm now available
The company plans to interface the algorithm into the Atellica Data Manager software in the future
Siemens Healthineers has received CE Mark for the ACUSON AcuNav Volume ICE catheter
The catheter transforms care delivery by enabling access to structural heart procedures for patients with tricuspid regurgitation and other pathologies
Siemens Healthineers lab-based antigen test available on high-throughput analyzers to support COVID-19 testing
The fast time-to-result includes a pretreatment process to inactivate the virus as a safeguard for laboratory staff handling the samples
Siemens Healthineers is the first leading diagnostics company offering a quantitative COVID-19 test to measure neutralizing antibodies
As SARS-CoV-2 vaccines become available, Siemens Healthineers is ready with fully automated antibody tests that can be used to help inform whether broad vaccination programs are working
Siemens Healthineers launches rapid antigen test for the detection of SARS-CoV-2
Easy-to-use test, which doesn't require specialized laboratory personnel or instruments, promises flexibility to test in locations that benefit from immediate results
Siemens collaborates with CDC to develop a novel process for standardizing SARS-CoV-2 assays
The collaboration aims to define threshold for neutralizing antibody sufficient to confer immunity
FDA clears AI-based MRI interpretation assistants from Siemens Healthineers
The AI-Rad Companion Brain MR and Prostate MR measures volumetric changes in brain, and segments prostate for targeted biopsy under MRI and ultrasound fusion imaging respectively






















